Dana-Farber Cancer Institute is a nonprofit cancer research and treatment center based in Boston, Massachusetts. Founded in 1947 by Sidney Farber, it is a teaching affiliate of Harvard Medical School and an NCI-designated Comprehensive Cancer Center. Adult oncology care is provided in collaboration with Brigham and Women’s Hospital, and pediatric oncology care with Boston Children’s Hospital.
Dana-Farber conducts basic, translational, and clinical research across oncology and hematology, including precision medicine, immuno-oncology, and biomarker-guided therapies. The institute operates extensive clinical trials programs and collaborates with academic, government, and industry partners to advance drug discovery and development. Its activities span laboratory science, computational biology, and population sciences to inform prevention, diagnosis, and treatment of cancer.
